Bourgeon Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-36
| Closed | -$1.19K | – | 126 |
|
|
2023
Q4 | $1.19K | Hold |
36
| – | – | ﹤0.01% | 327 |
|
|
2023
Q3 | $1.01K | Hold |
36
| – | – | ﹤0.01% | 311 |
|
|
2023
Q2 | $1.24K | Hold |
36
| – | – | ﹤0.01% | 301 |
|
|
2023
Q1 | $1.09K | Hold |
36
| – | – | ﹤0.01% | 288 |
|
|
2022
Q4 | $1.03K | Sell |
36
-94
| -72% | -$2.68K | ﹤0.01% | 324 |
|
|
2022
Q3 | $4K | Hold |
130
| – | – | ﹤0.01% | 270 |
|
|
2022
Q2 | $4K | Hold |
130
| – | – | ﹤0.01% | 255 |
|
|
2022
Q1 | $6K | Hold |
130
| – | – | ﹤0.01% | 245 |
|
|
2021
Q4 | $8K | Hold |
130
| – | – | ﹤0.01% | 225 |
|
|
2021
Q3 | $10K | Hold |
130
| – | – | ﹤0.01% | 227 |
|
|
2021
Q2 | $12K | Hold |
130
| – | – | ﹤0.01% | 223 |
|
|
2021
Q1 | $12K | Buy |
130
+118
| +983% | +$10.9K | ﹤0.01% | 221 |
|
|
2020
Q4 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 255 |
|